ATG7 and colorectal carcinoma: As standard chemotherapeutic agents used in CRC treatment are known to be linked to immunogenic responses [15,16], we analyzed whether the phenotype caused by Atg-7 knockout in CRC cell lines would have an impact on immunogenic cell death (ICD).